Cellebrite DI (CLBT) Research & Development (2020 - 2025)

Cellebrite DI (CLBT) has reported Research & Development for 6 consecutive years, with $29.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Research & Development rose 16.66% year-over-year to $29.9 million; the TTM figure through Dec 2025 stood at $113.9 million (up 15.71% YoY), while the FY2025 annual figure was $113.9 million, up 15.71% from the prior year.
• Research & Development came in at $29.9 million for Q4 2025 at Cellebrite DI, up from $28.1 million in the prior quarter.
• The five-year high for Research & Development was $29.9 million in Q4 2025, with the low at $14.9 million in Q1 2021.
• Average Research & Development over 5 years is $22.1 million, with a median of $21.4 million recorded in 2022.
• Across the five-year window, Research & Development jumped 31.7% in 2022 and retreated 5.47% in 2023, its largest moves.
• Year by year, Research & Development stood at $18.8 million in 2021, then increased by 4.78% to $19.7 million in 2022, then gained by 10.22% to $21.8 million in 2023, then advanced by 17.69% to $25.6 million in 2024, then climbed by 16.66% to $29.9 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered $29.9 million, $28.1 million, and $28.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.